The House Oversight and Reform Committee will hold a hearing to examine drug price increases later this month, the committee’s first since Democrats took control of the House.
In a statement, Oversight and Reform Committee Chairman Elijah CummingsElijah Eugene CummingsFormer GOP congressional candidate Kimberly Klacik suing Candace Owens for defamation Former Cummings staffer unveils congressional bid McCarthy, GOP face a delicate dance on Jan. 6 committee MORE (D-Md.) said the hearing will serve to launch a “broad review of the skyrocketing prices of prescription drugs.”
On Thursday, Cummings joined Sens. Cory BookerCory BookerSenate GOP signals they'll help bail out Biden's Fed chair Defense & National Security — Military starts giving guidance on COVID-19 vaccine refusals Senators preview bill to stop tech giants from prioritizing their own products MORE (D-N.J.), Bernie SandersBernie SandersManchin meets with Sanders, Jayapal amid spending stalemate America can end poverty among its elderly citizens Senate GOP signals they'll help bail out Biden's Fed chair MORE (I-Vt.) and other Democrats to introduce legislation aimed at lowering prescription drug prices.
The three proposed bills would allow importation of cheaper drugs from Canada, allow Medicare to negotiate drug prices and strip monopolies from drug companies if their prices were above the average price in other wealthy countries.
Drug prices have spiked over the past decade, putting a pinch on consumers as wages have failed to keep pace with the hikes. The drug pricing is a bipartisan concern, but the parties are divided on how best to solve the issue.
Democrats want Medicare to negotiate prices and want to allow Americans to buy cheaper prescription drugs from abroad, policies that are staunchly opposed by pharmaceutical companies.
Democratic lawmakers say Republicans were too easy on the industry when they controlled the House, and have vowed that will change now that they are in charge.